Neisi Dajomes, the Olympic champion from Ecuador, is allowed to return to competitive sports on August 1, 2026, following a 14-month period of ineligibility imposed by the International Testing Agency (ITA). This sanction is due to a doping violation as she tested positive for clomifene in April 2025. The suspension began on June 2, 2025, alleviating initial fears that it would extend through the entire Olympic cycle, which had concerned her supporters and fans.

The sanction was accepted by Dajomes without contest, as she acknowledged the violation of anti-doping regulations (ADRV) and agreed to the penalties imposed. This includes a disqualification of all her results from April 7, 2025, onwards. The reduction of the original sanction period resulted from the determination that the substance found in her system was related to a medical treatment for fertility and that there was no intent to enhance performance. This cooperation during the investigation likely influenced the ITA’s decision to lessen her ban.

As Dajomes prepares for her eventual return, the upcoming competitions she will participate in have not been detailed yet, but her case highlights the complexities surrounding doping violations and the role of medical treatments at elite levels of sports. Supporters of Dajomes look forward to her comeback, and the case underscores the importance of clear guidelines regarding doping violations, health treatments, and athlete support in similar situations.